Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Mol Carcinog. 2023 Jan 13;62(4):493–502. doi: 10.1002/mc.23501

Figure 3. cfDNA DMR subgroup prioritization and validation.

Figure 3.

A. Methylation levels in top regions that were identified based on the TCGA-concordant patient subgroup (P1, P4, P7 and P8)

B. (C,D,E) Kaplan-Meier plots validating the prognostic significance of four genes that include detected DMRs (based on the gene expression and survival data from the TCGA-HNSC data).